CureVac Newsroom

JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Maintains Target Price $16

Futu NewsNov 14 23:31

CureVac: Strong Financial Position and Promising Pipeline Justify Buy Rating

TipRanksNov 14 23:16

JMP Securities Reiterates Market Outperform on CureVac, Maintains $16 Price Target

BenzingaSep 16 22:05

CureVac Analyst Ratings

BenzingaSep 16 22:04

JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Maintains Target Price $16

Futu NewsSep 16 13:31

JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Maintains Target Price $16

Futu NewsSep 14 04:31

CureVac's Promising Cancer Vaccine Candidate CVGBM Elicits Buy Rating

TipRanksSep 14 03:37

Deutsche Bank Maintains CureVac(CVAC.US) With Hold Rating, Cuts Target Price to $3.9

Futu NewsSep 2 21:31

CureVac (CVAC) Receives a Hold From Deutsche Bank

TipRanksSep 2 20:39

Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), Vericel (VCEL) and Twist Bioscience (TWST)

TipRanksAug 20 15:15

JMP Securities Maintains Market Outperform on CureVac, Lowers Price Target to $16

BenzingaAug 16 20:03

CureVac Analyst Ratings

BenzingaAug 16 20:03

JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Cuts Target Price to $16

Futu NewsAug 16 12:31

CureVac: A Buy Rating Amidst Intellectual Property Litigation and Strong Valuation Metrics

TipRanksJul 12 00:49

Hold Rating on CureVac Maintained Amidst Strategic Shift and Market Uncertainty

TipRanksJul 10 16:59

Analysts' Opinions Are Mixed on These Healthcare Stocks: CureVac (CVAC), Insmed (INSM) and Quest Diagnostics (DGX)

TipRanksJul 8 16:42

JMP Securities Reiterates Market Outperform on CureVac, Maintains $18 Price Target

BenzingaJul 4 01:25

CureVac Analyst Ratings

BenzingaJul 4 01:25

CureVac's Strategic Realignment and Positive Financial Outlook Prompt Buy Rating

TipRanksJul 4 00:29

Buy Rating on CureVac: Positive Financial Outlook and Promising Vaccine Trials Fuel Optimism

TipRanksMay 23 22:10